about
MicroRNA in breast cancer: The association with BRCA1/2.BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethaneThyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.Expression of TopBP1 in hereditary breast cancerPrediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: identification of a BRCA1 ovarian cancer phenotype.BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cellsmiR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.Phenotype-genotype correlation in familial breast cancer.Folate and breast cancer: what about high-risk women?Systemic therapy options in BRCA mutation-associated breast cancer.Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.Male breast cancer: genetics, epigenetics, and ethical aspects.Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers.The determination of relationship between "excision repair cross-complementing group 1" (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer.Can we prevent BRCA1-associated breast cancer by RANKL inhibition?Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers.Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines.Invasive breast carcinomas with ATM gene variants of uncertain significance share distinct histopathologic features.Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer.Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in ItalyMicroenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity
P2860
Q33364654-EDC57534-29A0-427C-98CB-89D86C509972Q34283643-99CDF698-F007-4F90-9DAD-5BFE2D00DDF0Q35647617-36B93D35-E9DE-4F3F-97BC-7223BE9A3C86Q35683502-4677DE30-1171-4C00-A4F9-7B1E7AEFEF86Q35981641-E1AC953A-7917-40D7-8A08-762D2AA54754Q36173170-B238DDC5-0179-4B9D-92C8-F1E354EE76F2Q36406519-E5AB6DEA-B663-4B94-BE24-CD0692D628FBQ37511632-581B1D70-9432-4A10-A2CC-A41B96ECD979Q37521015-6E29B7C6-F56A-4AF0-9720-09EF322F5083Q37852615-030C3917-6D0F-454D-BEC8-B98EF4225EA9Q38024316-02EB8DF3-8187-472E-A859-CC269DA30FFBQ38025991-CFD0A751-89CB-434E-BCFA-7DB50459E73DQ38133084-B1E2FAEE-E6BF-483D-9011-ACD4EA74E74DQ38153187-CA86ACEB-D9BF-46FA-8CAF-979F82F59BF7Q38190905-C81F7D48-3244-40F7-80B9-0590F4251FCBQ38314472-4D465E4A-0F7A-4201-8739-55D2ABD6663DQ38335339-30CD8235-4C15-4768-9A7B-CA5AE949972AQ38991293-C3B10AA6-1242-4205-81CF-465E2EDC6427Q40514586-43468E93-A860-4974-8B39-DE97D50BAEEAQ41603225-B92E4423-2A68-431C-A55D-14D285AC95A9Q42484098-1C6F2AF2-5243-4811-82D9-D5A3ACFA837EQ44148124-59710A69-38A6-4503-95D0-E7FE30527CEAQ47097943-67F48948-53DD-4ACC-9D8D-44CB4DB94927Q47846573-334A3153-7C00-4D00-A6FE-6C5F73CC8855Q54336161-A171BA46-54EA-4F43-AA27-E9E2F6542928Q54522260-10573211-0CDE-403F-9A91-C7644C5327F9Q54603929-A588DD20-91C7-4D82-B6A7-04CCF68F37EBQ55711702-CF930674-8358-41DC-8FE4-5AC6B23F9216Q57419705-334FE3E9-1389-4F38-85BC-E5FD175C9A50Q58698836-7B558AB3-DADE-474F-9B2E-21356304C6D8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathology of hereditary breast cancer.
@en
Pathology of hereditary breast cancer.
@nl
type
label
Pathology of hereditary breast cancer.
@en
Pathology of hereditary breast cancer.
@nl
prefLabel
Pathology of hereditary breast cancer.
@en
Pathology of hereditary breast cancer.
@nl
P2860
P1433
P1476
Pathology of hereditary breast cancer.
@en
P2093
Leonard Da Silva
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.37
P478
23 Suppl 2
P577
2010-05-01T00:00:00Z